×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FENC – fennec pharmaceuticals inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FENC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
10:22 am
fenc
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
Low
Report
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
12/20
06:20 am
fenc
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales [Yahoo! Finance]
Low
Report
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales [Yahoo! Finance]
12/20
06:16 am
fenc
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Low
Report
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
12/19
06:17 am
fenc
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management [Yahoo! Finance]
Medium
Report
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management [Yahoo! Finance]
12/19
06:13 am
fenc
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
Medium
Report
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
12/17
08:15 am
fenc
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
12/12
07:13 am
fenc
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference [Yahoo! Finance]
Medium
Report
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference [Yahoo! Finance]
12/12
07:01 am
fenc
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
Medium
Report
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
06:13 am
fenc
fennec pharmaceuticals inc.
MISS
Report
-11.9%
fennec pharmaceuticals inc.
8/13/2024
06:05 am
fenc
fennec pharmaceuticals inc.
MISS
Report
-5.3%
fennec pharmaceuticals inc.
5/14/2024
06:03 am
fenc
fennec pharmaceuticals inc.
MISS
Report
-28.0%
fennec pharmaceuticals inc.
3/21/2024
06:00 am
fenc
fennec pharmaceuticals inc.
MISS
Report
-11.4%
fennec pharmaceuticals inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/20
04:38 pm
fenc
Form 8-K FENNEC PHARMACEUTICALS For: Dec 20
Low
Report
Form 8-K FENNEC PHARMACEUTICALS For: Dec 20
12/20
04:37 pm
fenc
Form 8-K FENNEC PHARMACEUTICALS For: Dec 18
Low
Report
Form 8-K FENNEC PHARMACEUTICALS For: Dec 18
12/5
04:24 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Dec 05 Filed by: Raykov Rosty
Medium
Report
Form 4 FENNEC PHARMACEUTICALS For: Dec 05 Filed by: Raykov Rosty
12/5
04:00 pm
fenc
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
Medium
Report
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
12/4
05:23 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Dec 01 Filed by: Raykov Rosty
Medium
Report
Form 4 FENNEC PHARMACEUTICALS For: Dec 01 Filed by: Raykov Rosty
12/3
04:03 pm
fenc
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
Low
Report
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
12/2
07:09 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Nov 30 Filed by: Andrade Robert
Low
Report
Form 4 FENNEC PHARMACEUTICALS For: Nov 30 Filed by: Andrade Robert
12/2
07:08 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Dec 02 Filed by: RALLIS CHRIS A
Low
Report
Form 4 FENNEC PHARMACEUTICALS For: Dec 02 Filed by: RALLIS CHRIS A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/13
Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™
11.9%
3/5 Form 8-K FENNEC PHARMACEUTICALS For: Mar 05 8.0%
2/11 Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency 7.8%
7/30 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
12/23 Hedge Funds Aren’t Crazy About Contango Oil & Gas Company (MCF) Anymore [Yahoo! Finance News] 3.7%
2/14 Q4/2019 12/31/2019 EPS -0.180 ZacksConsensus N/A ActVsEst N/A - N/A 3.6%
5/16 Form DEF 14A FENNEC PHARMACEUTICALS For: Jun 18 1.9%
2/18 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. 1.7%
5/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 1.7%
4/30 Fennec Announces Pricing of Public Offering 1.6%
3/5 Form 8-K FENNEC PHARMACEUTICALS For: Mar 05 8.0%
2/11 Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency 7.8%
7/30 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
12/23 Hedge Funds Aren’t Crazy About Contango Oil & Gas Company (MCF) Anymore [Yahoo! Finance News] 3.7%
2/14 Q4/2019 12/31/2019 EPS -0.180 ZacksConsensus N/A ActVsEst N/A - N/A 3.6%
5/16 Form DEF 14A FENNEC PHARMACEUTICALS For: Jun 18 1.9%
2/18 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. 1.7%
5/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 1.7%
4/30 Fennec Announces Pricing of Public Offering 1.6%
TOP News Decliners
4/29
Fennec Announces Proposed Public Offering of Common Shares
-13.6%
4/15 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -11.9%
6/19 Fennec Announces Results of Annual Meeting -8.0%
4/7 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.7%
1/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.9%
4/13 Form 8-K FENNEC PHARMACEUTICALS For: Apr 13 -3.9%
12/2 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -3.7%
5/9 Form 8-K FENNEC PHARMACEUTICALS For: May 09 -2.6%
6/26 Form S-8 FENNEC PHARMACEUTICALS -2.4%
11/12 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.230 ActVsEst 0.140 - Beat -2.0%
4/15 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -11.9%
6/19 Fennec Announces Results of Annual Meeting -8.0%
4/7 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.7%
1/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.9%
4/13 Form 8-K FENNEC PHARMACEUTICALS For: Apr 13 -3.9%
12/2 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -3.7%
5/9 Form 8-K FENNEC PHARMACEUTICALS For: May 09 -2.6%
6/26 Form S-8 FENNEC PHARMACEUTICALS -2.4%
11/12 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.230 ActVsEst 0.140 - Beat -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: